LAKEFRONT BIOTHERAPEUTICS NV (LKFT) — institutional ownership

81 funds reported holding LAKEFRONT BIOTHERAPEUTICS NV in their latest 13F filings, worth $981M in total (CUSIP 36315X101).

Largest holders

1. GILEAD SCIENCES, INC. (GILD) — $500M
2. TANG CAPITAL MANAGEMENT LLC — $114M
3. Madison Avenue Partners, LP — $103M
4. Prosight Management, LP — $61.3M
5. EcoR1 Capital, LLC — $50.0M
6. AMERIPRISE FINANCIAL INC (AMP) — $38.1M
7. SUSQUEHANNA INTERNATIONAL GROUP, LLP — $18.0M
8. DME Capital Management, LP — $14.5M
9. RENAISSANCE TECHNOLOGIES LLC — $12.2M
10. BlackRock, Inc. (BLK) — $10.1M

Famous investors holding it

• David Einhorn portfolio (Greenlight Capital)
• Renaissance Technologies portfolio (Renaissance Technologies)
• D. E. Shaw portfolio (D. E. Shaw & Co.)
• Izzy Englander portfolio (Millennium Management)
• Ken Griffin portfolio (Citadel Advisors)
• Two Sigma portfolio (Two Sigma Investments)

Insider buying and selling at LAKEFRONT BIOTHERAPEUTICS NV

Who owns the most LKFT stock?

The largest institutional holders in the latest 13F filings are GILEAD SCIENCES, INC. (GILD) ($500M), TANG CAPITAL MANAGEMENT LLC ($114M), Madison Avenue Partners, LP ($103M).

How many funds own LKFT?

81 funds reported holding it, worth $981M in total.